Absorbable Suture with Needle Maxon™ Polyglyconate HGU-46 5/8 Circle Taper Point Needle Size 0 Monofilament 100954239

Absorbable Suture with Needle Maxon™ Polyglyconate HGU-46 5/8 Circle Taper Point Needle Size 0 Monofilament

General Chemistry Reagent Architect™ Multigent® Iron For Architect c16000 Analyzer 3,060 Tests 100883340

General Chemistry Reagent Architect™ Multigent® Iron For Architect c16000 Analyzer 3,060 Tests

Reagent with Calibrator Kit Advia Centaur® Antibody Test SARS-CoV-2 IgG (sCOVG) For ADVIA Centaur XP / XPT / CP Immunoassay Systems 100 Tests 40 µL Sample Volum

$1,321.86
Advia Centaur,REAGENT, CENTAUR SARS-COV-2 IGG (100TEST/KT) D/S, UOM (KT)
SKU
1001196894
Ships directly from the manufacturer

Product Specifications

SLI Medical#1196894
Manufacturer #11207376
BrandADVIA Centaur®
ManufacturerSiemens
Country of OriginUnited States
ApplicationReagent with Calibrator Kit
Container TypeReadyPack
For Use WithFor ADVIA Centaur XP / XPT / CP Immunoassay Systems
FormReady-to-Use Liquid
Number of Tests100 Tests
Product DatingSLI Medical Acceptable Dating: we will ship >= 90 days
Sample TypeHuman Serum / Plasma Sample
SpecialtyRequires Refrigeration
Storage RequirementsChemiluminescent Immunoassay
Test CategorySARS-CoV-2 IgG (sCOVG)
Test FormatAntibody Test
Test Method41116010
Test Name40 µL Sample Volume
Test Type
UNSPSC Code
Volume

Features

  • The ADVIA Centaur SARS-CoV-2 IgG (sCOVG) assay is only for use under the Food and Drug Administration’s Emergency Use Authorization: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-serology-and-other-adaptive-immune-response-tests-sars-cov-2 Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA)
  • 42 U.S.C 263a
  • that meet requirements to perform moderate or high complexity tests The ADVIA Centaur® SARS-CoV-2 IgG (sCOVG) assay is a chemiluminescent immunoassay intended for qualitative and semi-quantitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (lithium heparin) using the using the ADVIA Centaur® XP
  • ADVIA Centaur® XPT
  • and ADVIA Centaur® CP Immunoassay Systems Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities The sensitivity of the ADVIA Centaur SARS-CoV-2 IgG (sCOVG) assay early after infection is unknown; negative results do not preclude acute SARS-CoV-2 infection False positive results for the ADVIA Centaur SARS-CoV-2 IgG (sCOVG) assay may occur due to cross-reactivity from pre-existing antibodies or other possible causes Samples should only be tested from individuals who are 15 days or more post symptom onset Kit Contents: 1 ReadyPack primary reagent pack containing ADVIA Centaur sCOVG Lite Reagent
  • Solid Phase
  • and Ancillary Well Reagent; 1 ReadyPack ancillary reagent pack containing ADVIA Centaur sCOVG DIL; ADVIA Centaur sCOVG master curve card 1 vial ADVIA Centaur sCOVG CAL low calibrator; 1 vial ADVIA Centaur sCOVG CAL high calibrator; ADVIA Centaur sCOVG CAL calibrator assigned value sheets and barcode labels
REAGENT, CENTAUR SARS-COV-2 IGG (100TEST/KT) D/S